Archive for March, 2006
Posted in Multiple Sclerosis Fundraising • Tags: , , at, Awards, Canada, Dinner, Division, Multiple, Multiple_Sclerosis_Fundraising, of, Opal, Pays, Quebec, Quebecers, Sclerosis, Society, The, Three, TO, Tribute
MONTREAL, QUEBEC–(CCNMatthews - March 21, 2006) - The fourth Opal Awards Dinner, named for Evelyn Opal, the founder of the Multiple Sclerosis Society of Canada (MSSC), was held on Wednesday, March 1st, at the Sheraton Centre in Montreal. This prestigious awards ceremony pays tribute to the outstanding achievements and social commitment of three Quebecers. This year’s Opal Awards Dinner raised $451,100 in donations and services for the Multiple Sclerosis Society of Canada, Quebec Division. The money will be used to support research and services for people with multiple sclerosis and their families.
Robert E. Brown, President and CEO of CAE Inc., received the highest distinction of the evening, the Grand Merit Opal Award, for his career achievements and philanthropy.
More →
Share This
Posted on March 22, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Copaxone, Lipitor • Tags: Copaxone, HELP, Lipitor, MS, STATINS, TO
17 March 2006
A DRUG to lower cholesterol could also help multiple sclerosis sufferers, say researchers.
Tests on mice with a similar auto-immune condition produced remarkable results when cholesterol busting statin Lipitor was combined with MS drug Copaxone.
It helped prevent or reduce paralysis, said scientists at the University of California and Stanford University Medical Center in California.
More →
Share This
Posted on March 22, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Copaxone, Lipitor • Tags: Combined, Copaxone, Cut, Disease, Dosages, Drug, Effects, Fewer, Half, in, Lipitor, May, Multiple, Negative, or, Reverse, Sclerosis, Side, Stop, with
March 16th 2006
Combining treatments may improve outcomes for patients with Multiple Sclerosis (MS), according to research done on mice and published online by the Journal of Clinical Investigation. Scott S. Zamvil and colleagues at the University of California, San Francisco found that mice treated with a combination of Glatiramer acetate (GA) and atorvastatin (Lipitor) demonstrated “a significant prevention and reversal of clinical MS severity” of MS symptoms.
Lipitor is a cholesterol lowering drug that has previously been shown to improve MS symptoms. Glatiramer acetate (Teva Pharmaceutical Industries Ltd.’s Copaxone) is a drug currently approved for MS treatment. The researchers found that treating MS with combinations of immune modulating drugs can greatly reduce MS disease.
More →
Share This
Posted on March 22, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Tysabri • Tags: Advisers, Drug, Endorse, FDA, Multiple, of, Return, Sclerosis, Tysabri
03.08.06, 12:00 AM ET
WEDNESDAY, March 8 (HealthDay News) — A U.S. Food and Drug Administration advisory panel voted unanimously Wednesday to allow the promising but controversial multiple sclerosis drug Tysabri back on the market.
The advisers continued to discuss certain controls on who could use the drug, which has been linked to a rare but potentially fatal brain infection. The panel members agreed to a manufacturer plan for a mandatory patient registry; they were scheduled to decide later in the day who would be allowed to enroll in the registry, and how tightly drug use would be limited, the Associated Press reported.
More →
Share This
Posted on March 22, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Alternative Treatment • Tags: Alternative_Treatment
I thought you would like to read the attached article:
DALLAS - Novel therapeutic strategies for multiple sclerosis are being developed to remove barriers to natural repair processes that might restore damaged myelin.
Click here for the full story: http://www.medpagetoday.com/Neurology/MultipleSclerosis/tb2/2777
More →
Share This
Posted on March 15, 2006 by SonjaHelga • There are no comments, hop to it!
Posted in Prevention and Early Detection • Tags: Prevention and Early Detection
03.09.06, 12:00 AM ET
THURSDAY, March 9 (HealthDay News) — A spinal fluid protein may prove useful in identifying people with the earliest stages of multiple sclerosis (MS), say researchers at Johns Hopkins University in Baltimore.
Currently, MS cannot be diagnosed with a simple blood sample or any other type of test.
More →
Share This
Posted on March 13, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Tysabri • Tags: Tysabri
By Associated Press
March 10, 2006
WASHINGTON - A multiple sclerosis drug pulled from the market a year ago because of a rare but life-threatening side effect is on track to return - but with some strong restrictions on how it’s used.
Advisers to the Food and Drug Administration have unanimously recommended that the government let Tysabri’s manufacturers resume sales - but only to patients enrolled in a mandatory registry designed to track, if not minimize, the risk of a rare brain infection linked to the drug.
More →
Share This
Posted on March 13, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Multiple Sclerosis Awareness • Tags: Multiple_Sclerosis_Awareness
3/12/2006 6:44 PM
By: News 10 Now Web Staff
It was a packed house at Carousel Center this weekend. But they were not window shopping, they were walking.
More than 500 people participated in the eighth annual Multiple Sclerosis walk. The walk kicked off MS Awareness Month. Participants walked either a three or eight mile course around the mall.
Multiple Sclerosis effects the central nervous system, which includes the brain and spinal cord.
More →
Share This
Posted on March 13, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Background Information
Our blog hopes to cover the following topics …
More →
Share This
Posted on March 8, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Suggested Reading • Tags: Suggested_Reading
Posted on March 1, 2006 by HART (1-800-HART) • There are no comments, hop to it!
